ABL Bio Inc. (KOSDAQ:298380)
35,250
-2,600 (-6.87%)
Nov 20, 2026, 3:30 PM KST
ABL Bio Market Cap
ABL Bio has a market cap or net worth of 1.97 trillion as of November 20, 2026. It is the 7,587th most valuable company in the world and the 173rd biggest in South Korea. Its market cap has decreased by 78.93% in one year.
Market Cap
1.97T
Enterprise Value
1.86T
Revenue
34.28B
Global Rank
Country Rank
#173 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since December 19, 2018, ABL Bio's market cap has increased from 608.61B to 1.97T, an increase of 224.27%. That is a compound annual growth rate of 16.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 1.97T | -82.10% |
| Dec 30, 2025 | 11.03T | 663.70% |
| Dec 30, 2024 | 1.44T | 22.53% |
| Dec 28, 2023 | 1.18T | 7.19% |
| Dec 29, 2022 | 1.10T | 5.54% |
| Dec 30, 2021 | 1.04T | -27.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HLB Co., Ltd. | 3.69T |
| SK bioscience | 3.03T |
| Hugel | 2.30T |
| Peptron | 2.07T |
| LigaChem Biosciences | 1.98T |
| Voronoi | 1.93T |
| OliX Pharmaceuticals | 1.81T |
| D&D Pharmatech | 1.60T |